Notably, the plasma level of IL-2R was significantly decreased in the CIK cell therapy group (P  < 0.05) (Table 6), indicating that downregulation of IL-2R might be involved in the anti-TB chemotherapy effect of CIK treatment. The gene discussed is IL2RA; the disease is tuberculosis.